Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS
· Delayed Price · Currency is USD
0.0498
-0.0068 (-11.97%)
Apr 2, 2025, 1:03 PM EST
Oncotelic Therapeutics Revenue
In the year 2023, Oncotelic Therapeutics had annual revenue of $70.00K.
Revenue
70.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
23.03M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 16.04M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.38M |
| American Oncology Network | 1.76B |
| Longduoduo Company | 6.01M |
Oncotelic Therapeutics News
- 2 days ago - Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI - GlobeNewsWire
- 8 days ago - Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference - GlobeNewsWire
- 5 weeks ago - Oncotelic Accesses Rapid IND Development Platform through Partnership with Medicilon - GlobeNewsWire
- 6 weeks ago - Oncotelic CEO Vuong Trieu to Present Groundbreaking Research on Transforming Growth Factor Beta 2 (TGFB2) at SWCR 2025 Conference - GlobeNewsWire
- 3 months ago - Oncotelic Therapeutics Implements PDAOAI Platform - GlobeNewsWire
- 5 months ago - ONCOTELIC CLINICAL PRESENTATIONS AT SITC 2024 - GlobeNewsWire
- 8 months ago - Product Manager Scott Myers to Present at 2nd Global Summit on Artificial Intelligence - GlobeNewsWire
- 10 months ago - ONCOTELIC TO PRESENT AT THE 20TH ANNUAL CONGRESS OF INTERNATIONAL DRUG DISCOVERY SCIENCE & TECHNOLOGY - GlobeNewsWire